Background: Post-treatment survivorship has not been extensively studied, despite long-standing evidence that after breast cancer treatment, women need continuing support to deal with their physical and psychosocial concerns. Objective: The purpose of this experimental pilot study was to examine the quality of life (QOL) and symptom outcomes of a psychoeducational support program for women in the first year of postYbreast cancer treatment survivorship. Methods: The sample consisted of 48 female breast cancer survivors randomly assigned to an intervention group (n = 25) and control group (n = 23). The psychoeducational support program consisted of individual face-to-face education, telephone-delivered health-coaching sessions, and small-group meetings. Study instruments were the Memorial Symptom Assessment ScaleYShort Form and Functional Assessment of Cancer TherapyYBreast questionnaire. Results: Compared with the control group, survivors in the intervention group reported higher QOL overall and higher emotional well-being. The intervention group reported lower psychological symptom distress than the control group. Conclusions: A psychoeducational support program may promote a better overall QOL and symptom experience in transition to survivorship among female breast cancer survivors. Implications for Practice: Oncology nurses are in a position to provide education and support to assist breast cancer survivors in
The 12-week compensatory cognitive training significantly improved the objective and subjective cognitive functioning of breast cancer patients. Because this was a pilot study, further research using a larger sample and longer follow-up durations is necessary.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.